Bioiversity Act 2002
Bioiversity Act 2002
P. ILANANGAI
IP CONSULTANT
ALTACIT GLOBAL
Biodiversity means
Biological diversity, or "biodiversity," refers to the
variety of life on earth. It includes diversity of
ecosystems, species and genes, and the ecological
processes that support them. India is one of the 12-
mega biodiversity countries of the world.
Patenting Life Form
Article 27(3) of the TRIPS agreement exclude plants
and animals other than micro-organisms, and
essentially biological processes for the production of
plants or animals other than non-biological and
microbiological processes from patentability.
This can be barrier to the technological and economic
development of the least developed countries, but such
exclusion in their respective country does not protect
the same from patentability in other region or country.
Example includes the issuance of U.K. patent covering
nuclear transfer technology, which was used to clone
the first animal, the famous „Dolly the Sheep‟
Biopiracy
Biopiracy is the illegal appropriation of life --
microorganisms, plants and animals (including
humans) -- and the traditional cultural knowledge
that accompanies it.
Biopiracy commonly operates through the
application of Intellectual Property Rights (IPR)
(primarily patents) to genetic resources and
traditional knowledge.
Bioprospecting
Bioprospecting is the search for biological
resources and accompanying indigenous
knowledge primarily for the purpose of
commercial exploitation.
Legal Cases
TURMERIC: In 1995, two non resident Indians at the University of
Mississippi Medical Centre, Jackson, (Suman K.Das and Hari Har
P.Cohly) were granted a US patent (Patent number 54015041) for
turmeric to be used for healing wounds. The Indian Council for
Scientific and Industrial Research (CSIR) filed a re-examination case
with the US Patent Office challenging the patent on the grounds of
“prior art”, i.e. existing public knowledge . The claim had to be backed
by written documentation claiming traditional wisdom. CSIR submitted
a document proof in the form of research paper published in 1953 in the
Journal of the Indian Medical Association. The US Patent Office upheld
the objection and cancelled the patent in 1997.
Neem
India's 10-year-long battle against the grant of a patent on the use of
NEEM as a fungicide has finally been won at the European Patent
Office (EPO).
Patent rights on a method for controlling fungi on plants by the aid of a
hydrophobic extracted neem oil had originally been granted by the EPO
in September 1994 to the United States Department of Agriculture
(USDA) and the New York-based multinational agribusiness
corporation WR Grace.
In June 1995, a legal opposition to the grant of this patent was filed
jointly by Dr Vandana Shiva, director of Delhi-based Research
Foundation for Science, Technology and Ecology (RFSTE), Ms Magda
Aelvoet of the Green Group in European Parliament and Ms Linda
Bullard of International Federation of Organic Agriculture Movements
(IFOAM).
Consequently, the EPO revoked the patent in May 2000. The MNC,
however, appealed the patent revocation. It is against this appeal that
the EPO has finally upheld its earlier decision, thereby revoking in its
entirety the patent rights once and for all on March 8, 2005.
Convention on Biological Diversity (CBD)